Editorial: Ketosis-Prone Diabetes - A New Subgroup of Patients with Atypical Type 1 and Type 2 Diabetes?

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 11, 2003, Pages 5087-5089

  Kitabchi, Abbas E ^a  

^a Univ of TN College of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; IMMUNOSUPPRESSIVE AGENT; INSULIN; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; AUTOIMMUNITY; CELL FUNCTION; CLINICAL FEATURE; CLINICAL TRIAL; DEMOGRAPHY; DIABETIC KETOACIDOSIS; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; EDITORIAL; GENE INTERACTION; GENETIC ANALYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PATHOGENESIS; PATIENT; PRIORITY JOURNAL; RECURRENT DISEASE; VACCINATION; CLASSIFICATION; NOTE;

DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC KETOACIDOSIS; HUMANS;

EID: 0344442690     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-031656     Document Type: Editorial

References (28)

1. Maldonado M, Hampe CS, Gaur LK, D'Amico S, Iyer D, Hammerle LP, Bolgiano D, Rodriguez L, Rajan A, Lernmark Å, Balasubramanyam A 2003 Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and β-cell functional classification, prospective analysis and clinical outcomes. J Clin Endocrinol Metab 88:5090-5098
2. Kitabchi AE, Umpierrez GE, Murphy MB, Barrett EJ, Kreisberg RA, Malone JI, Wall BM 2001 Management of hyperglycemic crises in patients with diabetes. Diabetes Care 24:131-153
3. American Diabetes Association 2003 Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 25:S5-S20
4. Alberti KGMM, Zimmet PZ, for the WHO Consultation 1998 Definition, diagnosis and classification of diabetes mellitus and its complications. Diabet Med 15:539-553
5. Ahren B, Corrigan CB 1985 Intermittent need for insulin in a subgroup of diabetic patients in Tanzania. Diabet Med 2:262-264
6. Winter WE, Maclaren NK, Riley WJ, Clarke DW, Kappy MS, Spillar RP 1987 Maturity-onset diabetes of youth in black Americans. N Engl J Med 316:285-291
7. Banerji MA, Chaiken RL, Huey H, Tuomi T, Norin AJ, Mackay IR, Rowley MJ, Zimmet PZ, Lebovitz HE 1994 GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes. Diabetes 43:741-745
8. Umpierrez GE, Casals MM, Gebhart SP, Mixon PS, Clark WS, Phillips LS 1995 Diabetic ketoacidosis in obese African-Americans. Diabetes 44:790-795
9. Umpierrez GE, Woo W, Hagopian WA, Isaacs SD, Palmer JP, Gaur LK, Nepom GT, Clark WS, Mixon PS, Kitabchi AE 1999 Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosis. Diabetes Care 22:1517-1523
10. Pitteloud N, Philippe J 2000 Characteristics of Caucasian type 2 diabetic patients during ketoacidosis and at follow-up. Schweiz Med Wochenschr 130:576-582
11. Yu E, Guo H, Wu T 2001 Factors associated with discontinuing insulin therapy after diabetic ketoacidosis in adult diabetic patients. Diabet Med 18:895-899
12. Pinero-Pilona A, Litonjua P, Aviles-Santa L, Raskin P 2001 Idiopathic type 1 diabetes in Dallas, Texas: a 5-year experience. Diabetes Care 24:1014-1018
13. Sobngwi E, Vexiau P, Levy V, Lepage V, Mauvais-Jarvis F, Leblanc H, Mbanya JC, Gautier JF 2002 Metabolic and immunogenetic prediction of long-term insulin remission in African patients with atypical diabetes. Diabet Med 19:832-835
14. Mauvais-Jarvis F, Sobngwi E, Porcher R, Riveline J, Kevorkian J, Guillausseau P, Charpentier G, Vexiau P, Gautier JF 2003 type 3 (ketosis-prone) diabetes mellitus: clinical pathophysiology and natural history of β-cell dysfunction and insulin resistance. Diabetes 52:A502
15. Umpierrez GE, Kelly JP, Navarrete JE, Casals MC, Kitabchi AE 1997 Hyperglycemic crises in urban blacks. Arch Intern Med 157:669-675
16. Groop LC, Bottazzo GF, Doniach D 1986 Islet cell antibodies identify latent type 1 diabetes in patients aged 35-75 years at diagnosis. Diabetes 35:237-241
17. Tuomi T, Groop LC, Zimmet PZ, Rowley MJ, Knowles W, Mackay IR 1993 Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 42:359-362
18. Tuomi T, Carlsson A, Li H, Isomaa B, Miettinen A, Nilsson A, Nissen M, Ehrnstrom BO, Forsen B, Snickars B, Lahti K, Forsblom C, Saloranta C, Taskinen MR, Groop LC 1999 Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48:150-157
19. Pozzilli P, Di Mario U 2001 Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult). Diabetes Care 24:1460-1467
20. Borg H, Gottsater A, Fernlund P, Sundkvist G 2002 A 12-year prospective study of the relationship between islet antibodies and β-cell function at and after the diagnosis in patients with adult-onset diabetes. Diabetes 51:1754-1762
21. Haiyan L, Lindholm E, Almgren P, Gustafsson A, Forsblom C, Groop L, Tuomi T 2001 Possible human leukocyte antigen-mediated genetic interaction between type 1 and type 2 diabetes. J Clin Endocrinol Metab 86:574-582
22. Lernmark A, Abdulahi P, Agardh C-D, Atkinson MA, Cilio C, Essen-Moller A, Harris RA, Hawa M, Kaufman DL, Klareskog L, Leslie RDG, Lethagen A-L, Londei M, Lynch K, Palmer M, Robertson JA, Tobin AJ 2003 A phase II clinical trial involving alum-formulated GAD65 vaccination of GAD65 autoantibody positive adult diabetes patients. Proc of the 63rd Annual Meeting of the American Diabetes Association, New Orleans, LA, 2003 (Abstract 32-LB)
23. Mathis D, Vence L, Benoist C 2001 β-cell death during progression to diabetes. Nature 414:792-798
24. Robertson RP, Olson LK, Zhang HJ 1994 Differentiating glucose toxicity from glucose desensitization: a new message from the insulin gene. Diabetes 43: 1085-1089
25. Sobngwi E, Gautier JF 2002 Adult-onset idiopathic type 1 or ketosis-prone type II diabetes: evidence to revisit diabetes classification. Diabetologia 45: 283-285
26. Bingley PJ, Bonifacio E, Mueller PW 2003 Diabetes antibody standardization program: first assay proficiency evaluation. Diabetes 52:1128-1136
27. The Diabetes Control and Complications Trial (DCCT) 1986 Design and methodological considerations for the feasibility phase. Diabetes 35:530-545
28. Field LL 2002 Genetic linkage and association studies of type 1 diabetes: challenges and rewards. Diabetologia 45:21-35